<?xml version="1.0" encoding="UTF-8"?>
<p>STI have been associated with increased HIV transmission 
 <xref rid="jia225361-bib-0010" ref-type="ref">10</xref>, 
 <xref rid="jia225361-bib-0011" ref-type="ref">11</xref>. Yet while remarkable progress has been made in reducing HIV transmission and improving lives of patients with anti‐retroviral therapy (ART), STI incidence is high and increasing in many regions 
 <xref rid="jia225361-bib-0001" ref-type="ref">1</xref> (Figure 
 <xref rid="jia225361-fig-0001" ref-type="fig">1</xref>). Although antiretroviral pre‐exposure prophylaxis (PrEP) is associated with reduced HIV transmission, STI incidence tends to be high among PrEP patients, as well among persons living with HIV and other vulnerable populations 
 <xref rid="jia225361-bib-0012" ref-type="ref">12</xref>, 
 <xref rid="jia225361-bib-0013" ref-type="ref">13</xref>, 
 <xref rid="jia225361-bib-0014" ref-type="ref">14</xref>. The biological and behavioural links between HIV and STIs suggest opportunities for improving STI control and surveillance through existing HIV prevention, testing, and treatment services.
</p>
